Related Experiment Video
Updated: Jan 22, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
Published on: December 29, 2021
Cannabinoid hyperemesis syndrome: A case study and discussion.
Eliza S Creedon1, Melony K Maloy2, Rita A DelloStritto3
1Medical City Plano, College of Nursing, Houston Center, Texas Woman's University, Denton, Texas.
Cannabinoid hyperemesis syndrome (CHS) is increasingly recognized. Early diagnosis and improved treatment plans are crucial for managing this condition, especially with rising cannabis use.
Area of Science:
- Medical Science
- Clinical Research
Background:
- Cannabinoid hyperemesis syndrome (CHS) was first identified in 2004.
- The pathophysiology of CHS is not well understood.
- CHS prevalence is increasing in healthcare settings due to cannabis legalization.
Observation:
- CHS symptoms are becoming clearer.
- Early recognition and effective treatment strategies are still lacking.
- Co-existing chronic conditions can complicate CHS presentation.
Findings:
- This article reviews literature from the past decade on CHS.
- It synthesizes clinical characteristics and pathogenesis.
- Diagnostic and treatment approaches are highlighted.
Implications:
- Improved recognition of CHS enables prompt and accurate diagnosis.
- Enhanced understanding can lead to better patient treatment plans.
- Nurse practitioners and healthcare providers play a key role in managing CHS.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Nephrotic Syndrome I : Introduction
Acute Coronary Syndrome I: Introduction
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

